effectiveness of madanaphala vamana in tamakshwasa and comparison with Jeemutaka and Ikshwaku Vamana in Tamakshwasa
Phase 3
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2020/06/025967
- Lead Sponsor
- Dr Kadam Sahebrao Kishanrao
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients presenting with Tamakshwasa (Bronchial asthma)[ICD10-j45.9]
Asthamatic bronchitis NOS
Late-onset asthma
Exclusion Criteria
patients ages below 20 and above 50 years
patients suffering from any complications or chronic illness
pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation and comparison of Madanaphala,Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5 days
- Secondary Outcome Measures
Name Time Method Ta access the Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5 days;To access the Madanaphala Vamana in TamakshwasaTimepoint: 5 days;To compare the Efficacy of Madamanaphala Vamana with Jeemutaka and Ikshwaku Vamana in TamakshwasaTimepoint: 5days;To find out the relative early clinical and biological improvement between treatment groupsTimepoint: 5days;To measure the incidence of adverse events, adverse drug reactions, safety,objective parameters(pft), lab parameters (haematology) and vital during the studyTimepoint: 5 days